MY121073A - Pharmaceutical formulations for aerosols with two or more active substances - Google Patents

Pharmaceutical formulations for aerosols with two or more active substances

Info

Publication number
MY121073A
MY121073A MYPI99002491A MYPI9902491A MY121073A MY 121073 A MY121073 A MY 121073A MY PI99002491 A MYPI99002491 A MY PI99002491A MY PI9902491 A MYPI9902491 A MY PI9902491A MY 121073 A MY121073 A MY 121073A
Authority
MY
Malaysia
Prior art keywords
aerosols
active substances
pharmaceutical formulations
active substance
propellant
Prior art date
Application number
MYPI99002491A
Inventor
Daniel Parick Mcnamara
George Anthony Destefano
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY121073(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/en
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY121073A publication Critical patent/MY121073A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO NEW PHARMACEUTICAL FORMULATIONS FOR AEROSOLS WITH AT LEAST TWO OR MORE ACTIVE SUBSTANCES FOR ADMINISTRATION BY INHALATION OR BY NASAL ROUTE. SPECIFICALLY, THE INVENTION RELATES TO PHARMACEUTICAL PREPARATIONS FOR PROPELLANT-DRIVEN METERED DOSE AEROSOLS USING A FLUOROHYDROCARBON (HFC) AS PROPELLANT, WHICH CONTAIN A COMBINATION OF ACTIVE SUBSTANCE OF TWO OR MORE ACTIVE SUBSTANCES, WHEREIN AT LEAST ONE ACTIVE SUBSTANCE IS PRESENT IN DISSOLVED FORM TOGETHER WITH AT LEAST ONE OTHER ACTIVE SUBSTANCE IN THE FORM OF SUSPENDED PARTICLES.
MYPI99002491A 1998-06-18 1999-06-16 Pharmaceutical formulations for aerosols with two or more active substances MY121073A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (en) 1998-06-18 1998-06-18 Stable aerosol formulations containing two or more bioactives used for pharmaceuticals
DE1998142963 DE19842963A1 (en) 1998-09-19 1998-09-19 Stable aerosol formulations containing two or more bioactives used for pharmaceuticals

Publications (1)

Publication Number Publication Date
MY121073A true MY121073A (en) 2005-12-30

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99002491A MY121073A (en) 1998-06-18 1999-06-16 Pharmaceutical formulations for aerosols with two or more active substances

Country Status (32)

Country Link
EP (1) EP1087750B1 (en)
JP (1) JP2003522102A (en)
KR (1) KR100600423B1 (en)
CN (1) CN1161104C (en)
AR (1) AR019690A1 (en)
AT (1) ATE253896T1 (en)
AU (1) AU759222B2 (en)
BG (1) BG65252B1 (en)
BR (1) BR9911351A (en)
CA (1) CA2335065C (en)
CO (1) CO5070580A1 (en)
CZ (1) CZ300910B6 (en)
DE (1) DE69912781T2 (en)
DK (1) DK1087750T3 (en)
EE (1) EE04450B1 (en)
ES (1) ES2211108T3 (en)
HR (1) HRP20000867B1 (en)
HU (1) HU229064B1 (en)
ID (1) ID27554A (en)
IL (2) IL140353A0 (en)
ME (1) ME00838B (en)
MY (1) MY121073A (en)
NO (1) NO329416B1 (en)
NZ (1) NZ509418A (en)
PL (1) PL193695B1 (en)
PT (1) PT1087750E (en)
RS (1) RS49977B (en)
RU (1) RU2218152C2 (en)
SK (1) SK284756B6 (en)
TR (1) TR200003721T2 (en)
TW (1) TW528606B (en)
WO (1) WO1999065464A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (en) 1998-11-25 2004-03-15 Chiesi Farma Spa Pressure metered dose inhaler.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa OPTIMIZED FORMULATIONS CONSTITUTED BY SOLUTIONS OF STEROIDS GIVEN BY INHALATION.
CA2317999C (en) 1999-09-11 2004-11-09 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
EP1248597B1 (en) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
JP5392880B2 (en) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ Stable pharmaceutical solution formulation for pressurized metered dose inhalers
DE10062712A1 (en) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics and corticosteroids
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (en) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics, corticosteroids and betamimetics
NZ531792A (en) 2001-09-18 2006-02-24 Nycomed Danmark Aps Compositions for treatment of common cold
JP2010184937A (en) * 2001-10-26 2010-08-26 Dey Lp Albuterol and ipratropium inhalation solution for relieving symptom of chronic obstructive pulmonary disease, kit, method for preparing one vessel containing the inhalation solution and method for preparing the inhalation solution
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN103462894A (en) * 2005-03-16 2013-12-25 霍尼韦尔国际公司 Medicament delivery formulations, devices and methods
DE102006053374A1 (en) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical formulation for aerosols with two or more active substances and at least one surface-active substance
DE102006017320A1 (en) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (en) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO.
RU2356537C2 (en) * 2007-07-25 2009-05-27 Закрытое Акционерное Общество (ЗАО) "Пульмомед" Pharmaceutical composition of metered aerosols containing antiasthmatic agents in form of suspensions, solutions, emulsions, solutions and emulsions
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US9119924B2 (en) 2009-03-17 2015-09-01 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (en) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Method for coating a surface of a component
EP3508239B1 (en) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalant apparatus and atomizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
MX2012005961A (en) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizer.
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP2512438B1 (en) 2009-12-16 2017-01-25 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
JP5874724B2 (en) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
BR122022010094B1 (en) 2014-05-07 2023-10-03 Boehringer Ingelheim International Gmbh INDICATING DEVICE AND CONTAINER
MX383195B (en) 2014-05-07 2025-03-13 Boehringer Ingelheim Int CONTAINER, NEBULIZER AND USE.
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
EP0673240B1 (en) * 1992-12-09 1999-03-24 Boehringer Ingelheim Pharmaceuticals Inc. Stabilized medicinal aerosol solution formulations
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Also Published As

Publication number Publication date
HK1037974A1 (en) 2002-03-01
ME00838B (en) 2008-09-29
HUP0104734A3 (en) 2003-05-28
IL140353A0 (en) 2002-02-10
AU4552199A (en) 2000-01-05
BG105033A (en) 2001-09-28
HU229064B1 (en) 2013-07-29
EE04450B1 (en) 2005-04-15
HRP20000867A2 (en) 2001-10-31
HRP20000867B1 (en) 2010-10-31
DE69912781T2 (en) 2004-10-21
RU2218152C2 (en) 2003-12-10
EP1087750A1 (en) 2001-04-04
DE69912781D1 (en) 2003-12-18
CA2335065C (en) 2008-06-03
WO1999065464A1 (en) 1999-12-23
TR200003721T2 (en) 2001-06-21
CA2335065A1 (en) 1999-12-23
EP1087750B1 (en) 2003-11-12
PT1087750E (en) 2004-02-27
BG65252B1 (en) 2007-10-31
PL193695B1 (en) 2007-03-30
EE200000759A (en) 2002-04-15
ES2211108T3 (en) 2004-07-01
NO329416B1 (en) 2010-10-18
IL140353A (en) 2006-09-05
KR100600423B1 (en) 2006-07-13
CZ300910B6 (en) 2009-09-09
CN1161104C (en) 2004-08-11
CZ20004750A3 (en) 2001-05-16
NZ509418A (en) 2003-06-30
YU80000A (en) 2003-04-30
AU759222B2 (en) 2003-04-10
DK1087750T3 (en) 2004-01-26
CO5070580A1 (en) 2001-08-28
SK284756B6 (en) 2005-11-03
TW528606B (en) 2003-04-21
ID27554A (en) 2001-04-12
ATE253896T1 (en) 2003-11-15
NO20006318L (en) 2001-01-30
KR20010072621A (en) 2001-07-31
NO20006318D0 (en) 2000-12-12
HUP0104734A2 (en) 2002-05-29
SK19392000A3 (en) 2001-07-10
BR9911351A (en) 2001-03-13
RS49977B (en) 2008-09-29
PL345685A1 (en) 2002-01-02
CN1307470A (en) 2001-08-08
JP2003522102A (en) 2003-07-22
AR019690A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
YU80000A (en) Pharmaceutical formulations for aerosols with two or more active substances
AU4260496A (en) Propellant mixture for aerosol formulation
YU56600A (en) Device for delivering an active agent to the lung of a human patient
DK0771189T3 (en) inhalant
BR9912170A (en) Pressurized metered dose inhalers and pharmaceutical aerosol formulations
HUP0203500A2 (en) Storage system for medicaments in powder form and inhaler provided therewith
IT1317846B1 (en) FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
BR9306112A (en) Separator for powder inhalers
BR0309117A (en) Inhalation kit comprising tiotropium inhalable powder
PT1257260E (en) PO FORMULATION
EA200100338A1 (en) METHOD AND DEVICE FOR INTRODUCTION OF EXISTING SUBSTANCE IN THE FORM OF AEROSOL IN LUNG PATIENT
PL337794A1 (en) Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
DE122011100049I1 (en) Stable pharmaceutical solution formulations for pressurized inhalers for the administration of metered doses.
DE69005951D1 (en) Medicines containing salmeterol and fluticasone.
IT1303788B1 (en) MEDICINAL AEROSOL FORMULATIONS.
PT1173244E (en) PO INHALER FOR A COMBINED MEDICINE
HU9601846D0 (en) Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
ATE343374T1 (en) FLUTICASONE PROPIONATE MEDICINAL PREPARATION
DK1303258T3 (en) New aerosol formulations containing a polar, fluorinated molecule
DK140393A (en) Iodized uracil nickeloside, this compound for use against an adenovirus infection, use of the compound for the manufacture of a drug for an adenovirus infection, pharmaceutical compositions containing the compound, and method for the preparation of the compound
KR960702320A (en) Stable Liquid Compositions of Gamma Interferon
DE69722610D1 (en) New inhalation preparations containing CR 2039 (Andolast)
PT742716E (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMIC ADMINISTRATION CONTAINING THE ACTIVE SUBSTANCE MORFINE-6-GLUCURONIDE
MY137747A (en) Nasal pharmaceutical piribedil composition
AR012341A1 (en) COMPOUND DERIVATIVES OF ESTRADIENES, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES